Gwendolyn Perch
Payments from drug & device makers
Across 149 payments — averaging $31.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$756
- AbbVie$547
- Vanda Pharmaceuticals Inc.$281
- Axsome Therapeutics, Inc.$277
- Catalyst Pharmaceuticals, Inc.$251
- plus $663 from 11 others
What the payments were for
- Travel & lodging$1,59434%
- Food & beverage$3,05666%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 4 | $1,876 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 49 | $756 |
| AbbVie | 38 | $547 |
| Vanda Pharmaceuticals Inc. | 14 | $281 |
| Axsome Therapeutics, Inc. | 10 | $277 |
| Catalyst Pharmaceuticals, Inc. | 10 | $251 |
| Alkermes, Inc. | 7 | $127 |
| Johnson & Johnson | 1 | $114 |
| Otsuka America Pharmaceutical, Inc. | 1 | $104 |
| SK Life Science, Inc. | 3 | $71 |
| Almatica Pharma LLC | 3 | $68 |
| Indivior Inc. | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $56 |
| Lilly USA, LLC | 1 | $20 |
| Livanova USA, Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,650 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 21 | $19,235 |
| Gabapentin | 35 | $344 |
| Atorvastatin Calcium | 42 | $284 |
| Duloxetine Hcl | 13 | $179 |
| Tizanidine Hcl | 14 | $168 |
| Hydroxyzine Hcl | 12 | $162 |
| Omeprazole | 27 | $158 |
| Levothyroxine Sodium | 26 | $157 |
| Famotidine | 16 | $141 |
| Potassium Chloride | 14 | $123 |
| Metformin Hcl | 26 | $113 |
| Fluticasone Propionate | 13 | $101 |
| Carvedilol | 12 | $76 |
| Prednisone | 11 | $72 |
| Amlodipine Besylate | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other family in Berea
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.